1 General Aspects
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Aspirin for the Primary Prevention of Cardiovascular Events: a Summary of the Evidence
Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence Michael Hayden, MD; Michael Pignone, MD, MPH; Christopher Phillips, MD; Cynthia Mulrow, MD, MSc Epidemiolgy power to precisely estimate major harms such as gastrointestinal bleeding and hemorrhagic stroke.4,5 Cardiovascular disease (CVD), including ischemic coronary heart disease (CHD), stroke, and The results of these first 2 randomized, controlled peripheral vascular disease, is the leading cause of trials were available to the members of the U.S. morbidity and mortality in the United States.1 In Preventive Services Task Force at the time of their 1997, the age-adjusted mortality rate due to 1996 recommendation.4,5 At that time, the Task coronary heart disease, cerebrovascular disease, and Force found insufficient evidence to recommend for atherosclerotic disease was 194 per 100,000 people, or against routine aspirin prophylaxis for the equating to more than 500,000 deaths per year.1 The primary prevention of myocardial infarction in estimated direct and indirect costs of CHD and asymptomatic people.6 stroke were $145 billion for 1999.2 Two additional large primary prevention trials Although the benefit of aspirin for patients with were published in 1998, and another was reported in known CVD is well established,3 the question of January 2001.7, 8, 9 In light of the new evidence, the whether aspirin reduces the risk of CVD in people U.S. Preventive Services Task Force sought to without known CVD is controversial. Two early reassess the value of aspirin for the primary randomized trials of aspirin in healthy men, the U.S. -
Ebook for A2.2 Chemistry
eBook for A2.2 Chemistry Chemistry in Medicine 5.11. [Pages 94 – 107 of A2.2 eBook] • You will be expected to be able to explain the use of indigestion remedies to cure excess hydrochloric acid in the stomach stating the types of compounds used and writing equations for their reactions. • You will be expected to be able to use a back titration to determine the percentage of an active ingredient in an indigestion remedy and perform various calculations on the titration. • You will be expected to be able to explain how to deal with variations in the pH values of skin, explain the role of fatty acids in skin pH and explain the use of corrosive chemicals in removing warts. • You will be expected to be able to recall and explain the use of silver nitrate in the treatment of eye diseases. • You will be expected to be able to explain the action of anticancer drugs, for example cisplatin in preventing DNA replication in cancer cells and how varying the structure of cisplatin affects the efficiency of anticancer activity • You will be expected to be able to carry out titrations to determine the concentration of aspirin in solution and carry out associated calculations. • You will be expected to be able to recall the synthesis of aspirin from salicylic acid and ethanoic anhydride and compare it with the use of ethanoic acid and ethanoyl chloride and explain why the sodium salt of aspirin is often used rather than aspirin. • You will be expected to be able to explain the use of GLC linked to MS to identify drugs and to determine their purity. -
Derivatives of Carboxylic Acid
Derivatives of Carboxylic Acid acid chloride carboxylate nitrile amide acid anhydride ester Nomenclature of Acid Halides IUPAC: alkanoic acid → alkanoyl halide Common: alkanic acid → alkanyl halide I: 3-aminopropanoyl chloride I: 4-nitropentanoyl chloride c: b-aminopropionyl chloride c: g-nitrovaleryl chloride I: hexanedioyl chloride c: adipoyl chloride Rings: (IUPAC only): ringcarbonyl halide I: benzenecarbonyl bromide I: 3-cylcopentenecarbonyl chloride c: benzoyl bromide Nomenclature of Acid Anhydrides Acid anhydrides are prepared by dehydrating carboxylic acids acetic anhydride ethanoic acid ethanoic anhydride I: benzenecarboxylic anhydride I: butanedioic acid I: butanedioic anhydride c: benzoic andhydride c: succinic acid c: succinic anhydride Some unsymmetrical anhydrides I: ethanoic methanoic I: benzoic methanoic anhydride anhydride I: cis-butenedioic c: benzoic formic anhydride anhydride c: acetic formic anhydride Nomenclature of Esters Esters occur when carboxylic acids react with alcohols I: phenyl methanoate I: t-butyl benzenecarboxylate I: methyl ethanoate c: phenyl formate c: methyl acetate c: t-butyl benzoate I: isobutyl I: cyclobutyl 2- I: dimethyl ethanedioate cyclobutanecarboxylate methylpropanoate c: cyclobutyl a- c: dimethyl oxalate c: none methylpropionate Cyclic Esters Reaction of -OH and -COOH on same molecule produces a cyclic ester, lactone. To name, add word lactone to the IUPAC acid name or replace the -ic acid of common name with -olactone. 4-hydroxy-2-methylpentanoic acid lactone -methyl- -valerolactone Amides Product of the reaction of a carboxylic acid and ammonia or an amine. Not basic because the lone pair on nitrogen is delocalized by resonance. Classes of Amides 1 amide has one C-N bond (two N-H). 2 amide or N-substituted amide has two C-N bonds (one N-H). -
Venous Thromboembolism
CLINICAL PRACTICE GUIDELINES MOH/P/PAK/264.13(GU) Prevention and Treatment of Venous Thromboembolism VTE Ministry of Health Malaysian Society of National Heart Association Academy of Medicine Malaysia Haematology of Malaysia Malaysia STATEMENT OF INTENT These guidelines are meant to be a guide for clinical practice, based on the best available evidence at the time of development. Adherence to these guidelines may not necessarily ensure the best outcome in every case. Every health care provider is responsible for the management options available locally. REVIEW OF THE GUIDELINES These guidelines were issued in 2013 and will be reviewed in 2017 or sooner if new evidence becomes available. Electronic version available on the following website: http://www.haematology.org.my DISCLOSURE STATEMENT The panel members had completed disclosure forms. None held shares in pharmaceutical firms or acted as consultants to such firms (details are available upon request from the CPG Secretariat). SOURCES OF FUNDING The development of the CPG on Prevention and Treatment of Venous Thromboembolism was supported via unrestricted educational grant from Bayer Healthcare Pharmaceuticals. The funding body has not influenced the development of the guidelines. ISBN 978-967-12100-0-0 9 789671 210000 August 2013 © Ministry of Health Malaysia 01 GUIDELINES DEVELOPMENT The development group for these guidelines consists of Haematologist, Cardiologist, Neurologist, Obstetrician & Gynaecologist, Vascular Surgeon, Orthopaedic Surgeon, Anaesthesiologist, Pharmacologist and Pharmacist from the Ministry of Health Malaysia, Ministry of Higher Education Malaysia and the Private sector. Literature search was carried out at the following electronic databases: International Health Technology Assessment website, PUBMED, MEDLINE, Cochrane Database of Systemic Reviews (CDSR), Journal full teXt via OVID search engine and Science Direct. -
Proefschrift-Banne-Nemeth.Pdf
Stellingen behorende bij het proefschrift Venous thrombosis following lower-leg cast immobilization and knee arthroscopy From a population-based approach to individualized therapy 1. A prophylactic regimen of low-molecular-weight-heparin for eight days after knee arthroscopy or during the complete immobilization period in patients with casting of the lower leg is not efective for the prevention of symptomatic venous thromboembolism. -this thesis- 2. For patients with a history of venous thromboembolism who are undergoing surgery or are treated with a lower leg cast, the risk of recurrent venous thromboembolism is high. -this thesis- 3. Estimating the risk of venous thromboembolism risk following lower leg cast immobilization or following knee arthroscopy is feasible by using a risk prediction model. -this thesis- 4. A targeted approach, by identifying high-risk patients who may beneft from a higher dose or longer duration of thromboprophylactic therapy, is a promising next step to prevent symptomatic VTE following lower leg cast immobilization or knee arthroscopy. -this thesis- 5. The best treatment strategy to prevent symptomatic venous thromboembolism following lower leg cast immobilization or following knee arthroscopy is yet to be determined. 6. Prognostic models are meant to assist and not to replace clinicians’ decisions. Accurate estimation of risks of outcomes can enhance informed decision making with the patient. -Adapted from PLoS Med 10(2): e1001381- 7. The frst developed prediction model is not the last. 8. Voor de dagelijkse klinische praktijk is het essentieel dat onderzoeksresultaten op de juiste manier worden geïnterpreteerd en toegepast. Om dit te waarborgen is een intensievere samenwerking tussen epidemiologen en dokters aan te raden. -
Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin
Thrombosis Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin Guest Editors: Christian Doutremepuich, Jawad fareed, Jeanine M. Walenga, Jean-Marc Orgogozo, and Marie Lordkipanidzé Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin Thrombosis Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin Guest Editors: Christian Doutremepuich, Jawad fareed, Jeanine M. Walenga, Jean-Marc Orgogozo, and Marie Lordkipanidze´ Copyright © 2012 Hindawi Publishing Corporation. All rights reserved. This is a special issue published in “Thrombosis.” All articles are open access articles distributed under the Creative Commons Attribu- tion License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Editorial Board Louis M. Aledort, USA Thomas Kickler, USA Johannes Oldenburg, Germany David Bergqvist, Sweden S. P. Kunapuli, USA Graham F. Pineo, Canada Francis J. Castellino, USA Jose A. Lopez, USA Domenico Prisco, Italy M. Cattaneo, Italy C. A. Ludlam, Uk Karin Przyklenk, USA Beng Hock Chong, Australia Nageswara Madamanchi, USA Ashwini Koneti Rao, USA Frank C. Church, USA Martyn Mahaut-Smith, UK F. R. Rickles, USA Giovanni de Gaetano, Italy P. M . Ma nnu cc i, Ita ly Evqueni Saenko, USA David H. Farrell, USA Osamu Matsuo, Japan Paolo Simioni, Italy Alessandro Gringeri, Italy Keith R. McCrae, USA C. Arnold -
The Approach to Thrombosis Prevention Across the Spectrum of Philadelphia-Negative Classic Myeloproliferative Neoplasms
Review The Approach to Thrombosis Prevention across the Spectrum of Philadelphia-Negative Classic Myeloproliferative Neoplasms Steffen Koschmieder Department of Medicine (Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation), Faculty of Medicine, RWTH Aachen University, Pauwelsstr. 30, D-52074 Aachen, Germany; [email protected]; Tel.: +49-241-8080981; Fax: +49-241-8082449 Abstract: Patients with myeloproliferative neoplasm (MPN) are potentially facing diminished life expectancy and decreased quality of life, due to thromboembolic and hemorrhagic complications, progression to myelofibrosis or acute leukemia with ensuing signs of hematopoietic insufficiency, and disturbing symptoms such as pruritus, night sweats, and bone pain. In patients with essential thrombocythemia (ET) or polycythemia vera (PV), current guidelines recommend both primary and secondary measures to prevent thrombosis. These include acetylsalicylic acid (ASA) for patients with intermediate- or high-risk ET and all patients with PV, unless they have contraindications for ASA use, and phlebotomy for all PV patients. A target hematocrit level below 45% is demonstrated to be associated with decreased cardiovascular events in PV. In addition, cytoreductive therapy is shown to reduce the rate of thrombotic complications in high-risk ET and high-risk PV patients. In patients with prefibrotic primary myelofibrosis (pre-PMF), similar measures are recommended as in those with ET. Patients with overt PMF may be at increased risk of bleeding and thus require a more individualized approach to thrombosis prevention. This review summarizes the thrombotic Citation: Koschmieder, S. The risk factors and primary and secondary preventive measures against thrombosis in MPN. Approach to Thrombosis Prevention across the Spectrum of Keywords: myeloproliferative neoplasms (MPN); polycythemia vera (PV); essential thrombocythemia Philadelphia-Negative Classic (ET); primary myelofibrosis (PMF); thrombosis; prevention; antiplatelet agents; anticoagulation; cy- Myeloproliferative Neoplasms. -
Early Russian Organic Chemists and Their Legacy
SpringerBriefs in Molecular Science Early Russian Organic Chemists and Their Legacy Bearbeitet von David Lewis 1. Auflage 2012. Taschenbuch. xii, 136 S. Paperback ISBN 978 3 642 28218 8 Format (B x L): 15,5 x 23,5 cm Gewicht: 237 g Weitere Fachgebiete > Chemie, Biowissenschaften, Agrarwissenschaften > Chemie Allgemein > Geschichte der Chemie Zu Inhaltsverzeichnis schnell und portofrei erhältlich bei Die Online-Fachbuchhandlung beck-shop.de ist spezialisiert auf Fachbücher, insbesondere Recht, Steuern und Wirtschaft. Im Sortiment finden Sie alle Medien (Bücher, Zeitschriften, CDs, eBooks, etc.) aller Verlage. Ergänzt wird das Programm durch Services wie Neuerscheinungsdienst oder Zusammenstellungen von Büchern zu Sonderpreisen. Der Shop führt mehr als 8 Millionen Produkte. Chapter 2 Beginnings 2.1 Introduction At the start of the twentieth century, organic chemistry was not yet 75 years old as a separate and legitimate sub-discipline of the science. Considerable progress had been made in these first seven decades, and the stage was set for the dramatic advances in the science to come in the following century. Most practicing organic chemists are familiar with many of the great German, French and English organic chemists whose work helped the fledgling discipline grow, but few are familiar with the role that Russian organic chemists of the nineteenth and early twentieth century played in the development of the science. And this is in spite of the fact that many of the named rules and reactions that one studies in the first course in organic chemistry are, in fact, of Russian origin. It is the intent of this book to help rectify that deficiency. -
Chemistry Is All Around Us
Chemistry is all around us. Everyone can and should understand basic chemistry. The Story Apart from those wanting to become chemists, students Central wanting to become doctors, nurses, physicists, Science Cover nutritionists, geologists, and pharmacists all need to study chemistry. It is important to remember that the Chemistry importance of chemistry would not be diminished BIMAN BASU over time; rather it will continue to remain a That is not all. There would be no drugs a science. It was primarily directed at efforts promising career prospect. – painkillers, antacids, or antibiotics – no to turn all kinds of substances into the polyester fibre or nylon stockings, no precious metal gold by early chemists, who stainless steel, no sugar-free soft drinks, were known as alchemists. We have heard IGHT from the moment we get up in even no Diwali illumination and fireworks about the “philosopher’s stone” using which the morning till we go to bed at without chemistry. Without chemistry, we the alchemists sought to turn any metal night, we come intimately close to R would not have such items as computers, into gold. Of course it was a silly thought, chemistry and things related to it. The CDs, DVDs, iPods, fuel for vehicles, oil to because no one can really turn one toothpaste we use to clean our teeth, the cook, refrigeration units, radios, televisions, element into another by mere touch! Still, toilet soap, shampoo, and plastic buckets batteries, and so much more. So, then, the alchemists made important we use to take bath, the plastic comb -
Obituary. Sir Edward Frankland
OBITUARY. SIR EDWARDFRANKLAND. E are again called upon to note the departure of a CO- W worker and master in our chosen field of science. Eulogy is not necessary. The good he has achieved lives after him, and we would merely note that the researches of Sir Edward Frankland. extending over a period of thirty years, relate to work in pure, applied, and physical chemistry. Those in pure chemistry were conducted at first in the laboratories of Playfair, Bunsen, and Liebig. They include subjects related to each other as follows : the conversion of the cyanogen group into the carboxyl group ; the change of the alkyl cyanides to the corresponding organic acids, the saponification of ethyl cyanide was announced by Edward Frankland and Hermann Kolbe when they were fellow assistants in Playfair’s laboratory in 1845. Although this reaction was not then pursued beyond the mono- basic acids, others applied it successfully in other directions. Then followed the action of metallic potassium upon ethyl cyanide and the polymerization of the latter, the isolation of the organic radicals, and the discovery of the organo-metallic com- pounds. Of these, which were investigated by Frankland throughout his scientific career, were zinc methyl and zinc ethyl, in. the study of which the author remarks: “ I had not pro- ceeded far in the investigation of these compounds before the facts brought to light began to impress upon me the existence of a fixity in the maximum combining value or capacity of saturation in the metallic elements which had never before been suspected.” The ready introduction of negative chlorine into bodies for a more electropositive constituent is a fact to which we give little thought. -
A TRANSNATIONAL NETWORK of CHEMICAL KNOWLEDGE: the PREPARADORES at the LISBON POLYTECHNIC SCHOOL in the 1860S and 1870S
26 Bull. Hist. Chem., VOLUME 39, Number 1 (2014) A TRANSNATIONAL NETWORK OF CHEMICAL KNOWLEDGE: THE PREPARADORES AT THE LISBON POLYTECHNIC SCHOOL IN THE 1860s AND 1870s Bernardo Jerosch Herold, Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, PT-1049-001 Lisboa, Portugal, [email protected] and Wolfram Bayer, Institut für Corpuslinguistik und Texttechnologie, Österreichische Akademie der Wissenschaften, Sonnenfelsgasse 19/8, A-1010 Vienna, Austria, [email protected] Antonio Augusto de Aguiar (1838-1887) was the graduated. Another co-author was Alexander Georg main author of the most important research in organic Bayer (1849-1928) of Bielitz in former Austrian Silesia, chemistry carried out in Portugal during the 19th century. who arrived in Lisbon four years after Lautemann, and Despite not attending any research school in Germany, has until recently evaded almost completely the attention France or Great Britain, Aguiar’s most important research of chemistry historians, in spite of his interesting profes- papers, on work carried out at the Chemical Laboratory sional career, patronized by his elder and more famous of the Lisbon Polytechnic School, were published in brother, Karl Joseph Bayer (1847-1904). The Lisbon Berichte der deutschen chemischen Gesellschaft between Polytechnic School employed Lautemann in 1864-65 and 1870 and 1874. Alexander Bayer from 1868 to 1872 as demonstrators in chemistry (preparadores), but between 1864 and 1876, How then did he acquire the knowledge, the in- three other chemists trained in Germany also worked spiration, and the experimental skills necessary for his as demonstrators at the Lisbon Polytechnic. Bayer and the other three chemists had in common that they were Vicente Lourenço (1822-1893), an élève of Adolphe recruited from the teaching laboratory of Carl Remigius Fresenius (1818-1897) in Wiesbaden. -
Final Program
In Memoriam: Final Program XXV Congress of the International Society on Thrombosis and Haemostasis and 61st Annual SSC Meeting June 20 – 25, 2015 Toronto, Canada www.isth2015.org 1 Final Program Table of Contents 3 Venue and Contacts 5 Invitation and Welcome Message 12 ISTH 2015 Committees 24 Congress Support 25 Sponsors and Exhibitors 27 ISTH Awards 32 ISTH Society Information 37 Program Overview 41 Program Day by Day 55 SSC and Educational Program 83 Master Classes and Career Mentorship Sessions 87 Nurses Forum 93 Scientific Program, Monday, June 22 94 Oral Communications 1 102 Plenary Lecture 103 State of the Art Lectures 105 Oral Communications 2 112 Abstract Symposia 120 Poster Session 189 Scientific Program, Tuesday, June 23 190 Oral Communications 3 198 Plenary Lecture 198 State of the Art Lectures 200 Oral Communications 4 208 Plenary Lecture 209 Abstract Symposia 216 Poster Session 285 Scientific Program, Wednesday, June 24 286 Oral Communications 5 294 Plenary Lecture 294 State of the Art Lectures 296 Oral Communications 6 304 Abstract Symposia 311 Poster Session 381 Scientific Program, Thursday, June 25 382 Oral Communications 7 390 Plenary Lecture 390 Abstract Symposia 397 Highlights of ISTH 399 Exhibition Floor Plan 402 Exhibitor List 405 Congress Information 406 Venue Plan 407 Congress Information 417 Social Program 418 Toronto & Canada Information 421 Transportation in Toronto 423 Future ISTH Meetings and Congresses 2 427 Authors Index 1 Thank You to Everyone Who Supported the Venue and Contacts 2014 World Thrombosis Day